HERTI 150MG INJ VIAL

About

Herti 150mg Injection contains Trastuzumab as its active ingredient and is primarily used in the treatment of HER2-positive breast cancer. In these patients, cancer cells overexpress HER2 proteins, which accelerate tumor growth by continuously signaling the cancer cells to multiply. Herti is also indicated for the treatment of metastatic gastric cancer in individuals with elevated HER2 levels.

HER2-positive breast cancers are known for their aggressive nature. This medication is a form of targeted therapy that works by specifically blocking the HER2 proteins responsible for the growth and spread of cancer. Patients are advised to use effective contraception during treatment and for at least 7 months after the final dose to avoid potential harm to an unborn baby.

Herti 150mg Injection is not recommended for individuals under 18 years of age, or for patients with severe breathing difficulties or those requiring oxygen therapy. Before starting treatment, inform your doctor if you have any heart conditions, experience shortness of breath, or have undergone any previous cancer treatments. It is also important to share a complete list of all current medications, supplements, and herbal products with your doctor prior to beginning therapy.

Uses

• Advanced and metastatic breast cancer
• Metastatic gastric cancer

Directions for use

This medicine will be administered by your doctor or nurse. Please do not attempt to self-administer it.


Side effects

• Nail disorders
• Weight loss
• Loss of appetite
• Bruising
• Dry mouth
• Liver  inflammation
• Muscle pain
• Asthma/ lung disorders
• Heart Problems
• Allergic reactions
• Kidney problems
• Breathing difficulties
• Fever
• Visual disturbances
• Nose bleeds or runny nose
• Hair loss
• Dizziness

Safety Measures

Alcohol - Speak with your doctor before consuming alcohol during treatment with Herti 150mg Injection, as safety information is limited.
Pregnancy - Do not use Herti 150mg Injection during pregnancy unless clearly instructed by your doctor. It may cause harm to the unborn baby. If you are pregnant or think you may be, consult your physician immediately.
Breastfeeding - Avoid breastfeeding while receiving Herti 150mg Injection and for at least seven months after your final dose, as the medication may harm your baby.
Liver - Inform your physician if you have any liver conditions before starting Herti 150mg Injection. In cases of severe liver impairment, dosage adjustments may be necessary.
Kidney - Herti 150mg Injection (Trastuzumab) has no significant direct effects on the kidneys in most patients. However, kidney function should still be monitored, especially in those with pre-existing kidney conditions or receiving other nephrotoxic drugs. Always consult your doctor before use if you have kidney problems.

Disclaimer

Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.